A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia
Robert W. Buchanan, Miriam Davis, Donald Goff, Michael F. Green, Richard S.E. Keefe, Andrew C. Leon, Keith H. Nuechterlein, Thomas Laughren, Robert Levin, Ellen Stover, Wayne Fenton, Steve R. Marder
Research output: Contribution to journal › Article › peer-review
401Scopus
citations
Fingerprint
Dive into the research topics of 'A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia'. Together they form a unique fingerprint.